Results 131 to 140 of about 1,013,409 (346)

Solubility; still a challenging subject in pharmaceutical sciences

Vitae, 2010
Solubility of a drug/drug candidate is one of the most important required physico-chemical properties in pharmaceutical area and nearly 40% of drug candidates fail to proceed to the higher trial phases of new drug development process because of their ...
Abolghasem Jouyban
doaj   +2 more sources

Artificial intelligence in pharmaceutical sciences: A comprehensive review

Medicine in Novel Technology and Devices
The integration of artificial intelligence (AI) and machine learning (ML) into pharmaceutical sciences has catalyzed transformative advancements across drug discovery, clinical development, manufacturing, and post-market surveillance.
Priyanka Kandhare, Mrunal Kurlekar, Tanvi Deshpande, Atmaram Pawar   +3 more
doaj   +1 more source

Assessing student perceptions of the Pharm.D. degree at a private tertiary medical university in India [PDF]

, 2017
Background: Pharmacy education in India has expanded to include the Doctorate of Pharmacy degree (Pharm.D.). With clinical practice in early development, job opportunities in India are limited. Graduates often consider pharmacy opportunities abroad. Aims:
Birnie, Christine R., Conn, Kelly, Nathan, Kobi T   +2 more
core   +1 more source

Chronic Blockade of the Melanocortin 4 Receptor Subtype Leads to Obesity Independently of Neuropeptide Y Action, with No Adverse Effects on the Gonadotropic and Somatotropic Axes**This work was supported by grants from the Swiss National Research Science Foundation (31–39729-93, 31–55732-98, and 32–04912 3–97) and in part by Ferring Pharmaceuticals Ltd. Research Laboratories. [PDF]

, 2000
Paula Raposinho, Einar Castillo, Violaine d’Allèves, Pierre Broqua, François Pralong, Michel L. Aubert   +5 more
openalex   +1 more source

Cytokine, Chemokine, and Neurofilament Light Chain Signatures in LGI1 Autoimmune Encephalitis

Annals of Clinical and Translational Neurology, EarlyView.
ABSTRACT Objectives To investigate the value of cytokine, chemokine, and neurofilament light chain (NfL) concentrations in predicting relapse risk, chronic epilepsy, and functional impairment in LGI1 autoimmune encephalitis (AE). Methods Cytokines/chemokines (IL‐1‐beta, IL‐2, IL‐4, IL‐5, IL‐6, IL‐8/CXCL8, IL‐10, IL‐12p70, IL‐13, IL‐17A, GM‐CSF, TNF ...
Albert Aboseif, Georgios Mangioris, Binxia Yang, Vanessa K. Pazdernik, Jeffrey W. Britton, Divyanshu Dubey, Eoin P. Flanagan, Sarosh R. Irani, Gregory S. Day, Charles L. Howe, A. Sebastian López‐Chiriboga, Andrew McKeon, John R. Mills, Yahel Segal, Michel Toledano, Ivana Vodopivec, Sean J. Pittock, Anastasia Zekeridou   +17 more
wiley   +1 more source

An Electrochemical Aptasensor Platform Based on Flower-Like Gold Microstructure-Modified Screen-Printed Carbon Electrode for Detection of Serpin A12 as a Type 2 Diabetes Biomarker

International Journal of Nanomedicine, 2020
Armin Salek Maghsoudi,1,* Shokoufeh Hassani,1,2,* Milad Rezaei Akmal,3 Mohammad Reza Ganjali,3,4 Kayvan Mirnia,5 Parviz Norouzi,3,4 Mohammad Abdollahi1,2 1Department of Toxicology and Pharmacology, School of Pharmacy, Tehran University of Medical ...
Salek Maghsoudi A, Hassani S, Rezaei Akmal M, Ganjali MR, Mirnia K, Norouzi P, Abdollahi M   +6 more
doaj  

[The Research Status and Future Direction of Pharmaceutical Sciences and Pharmaceutical Materials in China]. [PDF]

Sichuan Da Xue Xue Bao Yi Xue Ban, 2021
Zhang ZR.
europepmc   +1 more source

Long‐Term Evaluation of Givinostat in Duchenne Muscular Dystrophy, and Natural History Comparisons

Annals of Clinical and Translational Neurology, EarlyView.
ABSTRACT Objectives This ongoing, open‐label extension study is evaluating the long‐term safety, tolerability, and efficacy of givinostat, a Class I and II histone deacetylase inhibitor, in patients with Duchenne muscular dystrophy (DMD). Methods The recruited patients completed one of two prior clinical studies (one Phase 2 and one Phase 3 [EPIDYS ...
Craig M. McDonald, Michela Guglieri, Dragana Vučinić, Gyula Acsadi, John F. Brandsema, Claudio Bruno, Erika L. Finanger, Amy Harper, Mercedes Lopez Lobato, Riccardo Masson, Nuria Muelas, Francina Munell, Yoram Nevo, Yann Péréon, Han Phan, Valeria A. Sansone, Mariacristina Scoto, Tracey Willis, Richard S. Finkel, Krista Vandenborne, Sara Cazzaniga, Silvia Montrasio, Federica Alessi, Paolo Bettica, Eugenio Mercuri, for the Givinostat Study 51 Investigators, the Cooperative International Neuromuscular Research Group (CINRG) Duchenne Natural History Study (DNHS) Investigators, the ImagingDMD Investigators, Enrico Bertini, Giacomo Pietro Comi, Eugenio Maria Mercuri, Giuseppe Vita, Sonia Messina, Claudio Bruno, Riccardo Masson, Valeria Sansone, Nathalie Goemans, Liesbeth De Waele, Laurent Servais, Teresa Gidaro, Odile Boespflug‐Tanguy, Yann Péréon, Jessika Johannsen, Astrid Blaschek, Ulrike Schara‐Schmidt, Erik Niks, Imelda de Groot, Saskia Houwen‐van Opstal, Andres Nascimento, Juan Jesus Vilchez, Nuria Muelas, Francina Munell, Marcos Madruga Garrido, Mercedes Lopez Lobato, Michaela Guglieri, Tracey Willis, Stefan Spinty, Daniel Hawcutt, Mariacristina Scoto, Jean K. Mah, Laura McAdam, Kathryn Selby, Katherine Mathews, Craig McDonald, Craig Zaidman, Barry Byrne, John Brandsema, Gyula Acsadi, Chamindra Laverty, Amy Harper, Erika Finanger, Han Phan, Yoram Nevo, Vedrana Milic Rasic, Dragana Vucinic   +74 more
wiley   +1 more source

Pharmaceutical botany; a text-book for students of pharmacy and science,

, 1920
Heber W. Youngken
openalex   +2 more sources

High‐Pressure Biotechnology in Medicine and Pharmaceutical Science [PDF]

, 2001
Patrick Masson, Carole Tonello, Claude Balny   +2 more
openalex   +1 more source